Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,892
Total Claims
$2.2M
Drug Cost
884
Beneficiaries
$2,494
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-34%
Opioid rate vs peers
2.5% vs 3.8% avg
+112%
Cost per patient vs peers
$2,494 vs $1,174 avg
+71%
Brand preference vs peers
15.2% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.5%
Opioid Rate
373
Opioid Claims
$4,234
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,238 claims · $1.8M
Generic: 12,517 claims · $368K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 309 | $310K |
| Sacubitril/Valsartan | 272 | $301K |
| Semaglutide | 150 | $224K |
| Empagliflozin | 60 | $87K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $86K |
| Linagliptin | 62 | $60K |
| Rivaroxaban | 49 | $58K |
| Sitagliptin Phosphate | 28 | $50K |
| Fluticasone/Umeclidin/Vilanter | 57 | $42K |
| Tirzepatide | 26 | $37K |
| Semaglutide | 20 | $30K |
| Dulaglutide | 17 | $27K |
| Ticagrelor | 34 | $27K |
| Dapagliflozin Propanediol | 23 | $25K |
| Insulin Aspart | 20 | $24K |
Prescribing Profile
Patient Profile
74
Avg Age
49%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About